CompletedNot Applicable

Factors Impacting the Prevalence of MDR Bacteria

Iraq400 participantsStarted 2022-03-01

Plain-language summary

1. To determine the prevalence of multidrug resistance bacteria in patient with different infections 2. To evaluate patients' predictive risk factors of antimicrobial resistance 3. To assess the association between patients' factors and prevalence of MDR bacteria

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who were screened for MDR bacteria * patients who accepted to participate in the study Exclusion Criteria: * patients with no growth media * patients who cannot communicated

What they're measuring

Prevalence of multidrug resistance bacteria in isolated patient specimen

Timeframe: based line value (zero months)

Association of patient's factors with prevalence of multidrug resistance Bacteria.

Timeframe: based line value (zero months)

Trial details

NCT IDNCT05100407

SponsorKufa University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-01

View on ClinicalTrials.gov More Multi-antibiotic Resistance trials